Hélène Sicard

1.7k total citations
42 papers, 1.4k citations indexed

About

Hélène Sicard is a scholar working on Immunology, Dermatology and Pathology and Forensic Medicine. According to data from OpenAlex, Hélène Sicard has authored 42 papers receiving a total of 1.4k indexed citations (citations by other indexed papers that have themselves been cited), including 35 papers in Immunology, 13 papers in Dermatology and 9 papers in Pathology and Forensic Medicine. Recurrent topics in Hélène Sicard's work include Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (17 papers) and Cutaneous lymphoproliferative disorders research (13 papers). Hélène Sicard is often cited by papers focused on Immune Cell Function and Interaction (21 papers), T-cell and B-cell Immunology (17 papers) and Cutaneous lymphoproliferative disorders research (13 papers). Hélène Sicard collaborates with scholars based in France, United States and United Kingdom. Hélène Sicard's co-authors include Jean‐Jacques Fournié, François Romagné, Sophie Ingoure, Marc Bonneville, Jérôme Tiollier, Cécile Bonnafous, Guy Laurent, Christine Bezombes, Loïc Ysebaert and Armand Bensussan and has published in prestigious journals such as Journal of Clinical Oncology, Blood and The Journal of Immunology.

In The Last Decade

Hélène Sicard

39 papers receiving 1.3k citations

Peers

Hélène Sicard
W.A. Macdonald Australia
Melissa de los Reyes United States
Cynthia M. Fehres Netherlands
Jennifer Mariner United States
Danijel Dojcinovic Switzerland
L Gemmell United States
W.A. Macdonald Australia
Hélène Sicard
Citations per year, relative to Hélène Sicard Hélène Sicard (= 1×) peers W.A. Macdonald

Countries citing papers authored by Hélène Sicard

Since Specialization
Citations

This map shows the geographic impact of Hélène Sicard's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Hélène Sicard with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Hélène Sicard more than expected).

Fields of papers citing papers by Hélène Sicard

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Hélène Sicard. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Hélène Sicard. The network helps show where Hélène Sicard may publish in the future.

Co-authorship network of co-authors of Hélène Sicard

This figure shows the co-authorship network connecting the top 25 collaborators of Hélène Sicard. A scholar is included among the top collaborators of Hélène Sicard based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Hélène Sicard. Hélène Sicard is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Jeammet, Louise, et al.. (2024). Apoptosis Inhibitor 5: A Multifaceted Regulator of Cell Fate. Biomolecules. 14(1). 136–136. 5 indexed citations
2.
Salembier, Chloé, Blanche Segrestin, Benoît Weil, et al.. (2021). A theoretical framework for tracking farmers’ innovations to support farming system design. Agronomy for Sustainable Development. 41(5). 32 indexed citations
3.
Bagot, M., Pierluigi Porcu, Anne Marie‐Cardine, et al.. (2019). IPH4102, a first-in-class anti-KIR3DL2 monoclonal antibody, in patients with relapsed or refractory cutaneous T-cell lymphoma: an international, first-in-human, open-label, phase 1 trial. The Lancet Oncology. 20(8). 1160–1170. 109 indexed citations
4.
Hurabielle, Charlotte, C. Ram‐Wolff, Hélène Sicard, et al.. (2017). Usefulness of KIR3DL2 to Diagnose, Follow-Up, and Manage the Treatment of Patients with Sézary Syndrome. Clinical Cancer Research. 23(14). 3619–3627. 29 indexed citations
5.
Benoit, Bernice, Geraldine M. O’Connor, Landon K. Oetjen, et al.. (2016). CD164 identifies CD4+ T cells highly expressing genes associated with malignancy in Sézary syndrome: the Sézary signature genes, FCRL3, Tox, and miR-214. Archives of Dermatological Research. 309(1). 11–19. 19 indexed citations
6.
Sicard, Hélène, Cécile Bonnafous, Ariane Morel, et al.. (2015). A novel targeted immunotherapy for CTCL is on its way: Anti-KIR3DL2 mAb IPH4102 is potent and safe in non-clinical studies. OncoImmunology. 4(9). e1022306–e1022306. 18 indexed citations
7.
Poupot, Mary, Séverine Fruchon, Frédéric Pont, et al.. (2014). The PPARα pathway in Vγ9Vδ2 T cell anergy. Cellular & Molecular Biology Letters. 19(4). 5 indexed citations
8.
Cimini, Eleonora, Cécile Bonnafous, Hélène Sicard, et al.. (2013). In Vivo Interferon-Alpha/Ribavirin Treatment Modulates Vγ9Vδ2 T-Cell Function During Chronic HCV Infection. Journal of Interferon & Cytokine Research. 33(3). 136–141. 5 indexed citations
9.
Chen, Crystal Y., Shuyu Yao, Dan Huang, et al.. (2013). Phosphoantigen/IL2 Expansion and Differentiation of Vγ2Vδ2 T Cells Increase Resistance to Tuberculosis in Nonhuman Primates. PLoS Pathogens. 9(8). e1003501–e1003501. 94 indexed citations
10.
Laws, Thomas R., Michelle Nelson, Cécile Bonnafous, et al.. (2013). In Vivo Manipulation of γ9+ T Cells in the Common Marmoset (Callithrix Jacchus) with Phosphoantigen and Effect on the Progression of Respiratory Melioidosis. PLoS ONE. 8(9). e74789–e74789. 8 indexed citations
11.
Cimini, Eleonora, Cécile Bonnafous, Veronica Bordoni, et al.. (2012). Interferon-α Improves Phosphoantigen-Induced Vγ9Vδ2 T-Cells Interferon-γ Production during Chronic HCV Infection. PLoS ONE. 7(5). e37014–e37014. 17 indexed citations
12.
Bennouna, Jaafar, Vincent Lévy, Hélène Sicard, et al.. (2010). Phase I study of bromohydrin pyrophosphate (BrHPP, IPH 1101), a Vγ9Vδ2 T lymphocyte agonist in patients with solid tumors. Cancer Immunology Immunotherapy. 59(10). 1521–1530. 84 indexed citations
13.
Braza, Mounia S., Anouk Caraux, Thérèse Rousset, et al.. (2009). γδ T Lymphocytes Count Is Normal and Expandable in Peripheral Blood of Patients with Follicular Lymphoma, Whereas It Is Decreased in Tumor Lymph Nodes Compared with Inflammatory Lymph Nodes. The Journal of Immunology. 184(1). 134–140. 15 indexed citations
14.
Salot, Samuel, Sylvain Bercegeay, Brigitte Dréno, et al.. (2009). Large scale expansion of Vγ9Vδ2 T lymphocytes from human peripheral blood mononuclear cells after a positive selection using MACS “TCR γ/δ + T cell isolation kit”. Journal of Immunological Methods. 347(1-2). 12–18. 14 indexed citations
15.
Laurent, Guy, Philippe Solal‐Céligny, Pierre Soubeyran, et al.. (2009). Phase I/II Study of IPH1101, γσ T Cell Agonist, Combined with Rituximab, in Low Grade Follicular Lymphoma Patients.. Blood. 114(22). 1649–1649. 6 indexed citations
16.
Sicard, Hélène, et al.. (2008). Synthesis and biological activity of phosphonate analogues and geometric isomers of the highly potent phosphoantigen (E)-1-hydroxy-2-methylbut-2-enyl 4-diphosphate. HAL (Le Centre pour la Communication Scientifique Directe). 2 indexed citations
17.
Cendron, Delphine, Sophie Ingoure, Angelo Martino, et al.. (2007). A tuberculosis vaccine based on phosphoantigens and fusion proteins induces distinct γδ and αβ T cell responses in primates. European Journal of Immunology. 37(2). 549–565. 36 indexed citations
18.
Sicard, Hélène, Sophie Ingoure, Jean‐Jacques Fournié, et al.. (2005). In Vivo Immunomanipulation of Vγ9Vδ2 T Cells with a Synthetic Phosphoantigen in a Preclinical Nonhuman Primate Model. The Journal of Immunology. 175(8). 5471–5480. 165 indexed citations
19.
Espinosa, Éric, Christian Belmant, Hélène Sicard, et al.. (2001). Y2K+1 state-of-the-art on non-peptide phosphoantigens, a novel category of immunostimulatory molecules. Microbes and Infection. 3(8). 645–654. 34 indexed citations
20.
Belmant, Christian, Éric Espinosa, Franck Halary, et al.. (1999). Conventional and non-conventional recognition of non-peptide antigens by T lymphocytes. Comptes Rendus de l Académie des Sciences - Series III - Sciences de la Vie. 322(11). 919–924. 4 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026